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Abstract: In clinical practice, vertebral compression fractures occur after trauma and 
  osteoporosis. Kyphoplasty is a minimally invasive procedure using bone filler material for the 
treatment of such fractures. A full synthetic injectable bone substitute (SIBS) was manufactured 
by means of spray drying. The aim of this study was to characterize the SIBS and to analyze 
the remodelling process during degradation of the biomaterial and new bone formation after 
implantation. SIBS is an aqueous suspension of donut-like microparticles. These microparticles 
consist of nanocrystallites of synthetic hydroxyapatite embedded in amorphous silica gel. After 
implantation of SIBS in a proximal tibial diaphyseal defect in 52 rats, grafts were harvested 
for subsequent analysis on different days. Newly formed bone originating from endosteum 
was observed on day 6. Hematomas in the medullary space and cortical wounds disappeared 
on day 12. The wound region was completely replaced by a composite of newly formed can-
cellous bone, extracellular matrix, and SIBS. At day 63 the cortical defect was fully healed by 
bone, while newly formed bone in the medullary space almost disappeared and was replaced 
with bone marrow. In conclusion, SIBS demonstrated a unique structure with osteoinductive and 
bioresorbable properties, which induced fast bone regeneration. Therefore, a clinical application 
of SIBS for kyphoplasty is promising.
Keywords: bone remodelling, electron microscopy, histomorphometry, nanotechnology,   tissue 
engineering
Introduction
Morbidity due to osteoporosis is increasing in older people. A common complication 
of osteoporosis is bone fracture, especially vertebral fracture.1 At present, percutaneous 
vertebroplasty or kyphoplasty represents an effective method for treatment of vertebral 
fractures.2 In the past, autologous bone was the first choice for treatment of bone defects, 
but it can be difficult to obtain sufficient amounts of autograft material. In addition, the 
risks of additional surgical incisions, morbidity at the donor site, and potential serious 
complications cannot be ignored.3 Different types of bone substitutes are already used 
in orthopedic and plastic reconstructive surgery. Due to the development of minimally 
invasive surgery, implantation of synthetic injectable biomaterials is widely applied to 
cure osteoporotic fractures of the spine or extremities.4 Such injectable bone substitutes 
should exhibit biocompatibility and rapid biodegradability.
Hydroxyapatite (HA), a calcium phosphate (Ca10(PO4)6(OH)2), represents the 
main component of bone in vertebrates. Silicon is an essential trace element that 
plays an active role in human bone mineralization and calcification. It has been shown 
that silicon is essential for the formation of connective tissue, bone   mineralization, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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and stimulation of osteoblast proliferation.5 In the last 
three decades, biomaterials based on hydroxyapatite and/
or silicon have been widely used in orthopedic and dental 
areas because of their osteoconduction capacity.6 Com-
pared with pure hydroxyapatite, silicon incorporated into 
hydroxyapatite increases dissolution, leading to fast bone 
remodelling.7 Previous animal studies showed that bone 
tissue engineered scaffolds made from hydroxyapatite and 
silica are biocompatible, osteoconductive, and biodegrad-
able.8 A fully synthetic injectable bone substitute (SIBS), 
consisting of donut-like microparticles, was developed by 
our group. The majority of the particles are a few microns 
in diameter. Their nanostructure and composition can be 
described as nanocrystallites of synthetic hydroxyapatite 
embedded in a highly porous matrix of amorphous silica gel 
(mass fractions HA:SiO2 = 76:24). Amorphous silica gel is 
an incomplete linkage of polysilicic acid. It is characterized 
by numerous open bonds, which are always ≡Si—OH or 
≡Si—O− groups (depending on the pH).9 The open bonds 
and the spray-drying process produce a high specific surface 
area and the porosity of the particles is about 81%.
Initially, this biomaterial, NanoBone® (Artoss GmbH, 
  Rostock, Germany), was developed as a granulate, afterwards as 
a form block.10 Microparticles are the third   application form.
The goals of the present study were to determine the 
physical and chemical characteristics of these microparticles 
and to analyze the healing process in tibial defects after 
implantation of SIBS by means of histology, planimetric 
analysis of new bone formation and biomaterial degradation, 
electron microscopic methods, and energy-dispersive X-ray 
spectroscopy (EDXS).
Materials and methods
Bone grafting substitute
All the chemicals used were specified as reagent Ph Eur 
grade (Sigma-Aldrich Chemie GmbH, Munich, Germany) 
and were used without further purification. Preparation of the 
full synthetic injectable bone substitute (SIBS) was done as 
follows. Nanocrystalline HA was produced by precipitation 
of diluted solutions of calcium chloride and sodium hydrogen 
phosphate in a special reactor at controlled temperature and 
pH, adjusted with ammonia solution. A molar ratio of calcium 
to phosphate of 1.67 was used. HA crystals produced were 
washed three times with deionized water followed by a triple 
rinsing with pure ethanol. The slip of nanocrystalline HA was 
mixed with pure ethanol and a silica sol to get a ratio in weight 
of HA:SiO2 of 76:24. The sol was obtained by hydrolysis of 
tetraethyl orthosilicate (TEOS) with an acid catalyst. A molar 
ratio of water to TEOS of 4 was used. After homogenization 
by means of ultrasonic treatment, the mixture was spray dried 
at 200°C with a Mini Spray Dryer B-290 in combination with 
Inert Loop B-295 (Buchi, Flawil, Switzerland). Using a two-
fluid nozzle, the mixture was sprayed into fine droplets using 
compressed nitrogen. These were dried quickly in the drying 
chamber to donut-like microparticles. With a further heat 
treatment at 700°C in air the organic remains were removed 
from the biomaterial.
characterization
The nanoporous structure of the silica gel matrix was 
characterized by mercury porosimetry and gas adsorp-
tion. The gas adsorption data were treated according to the 
Brunauer–Emmett–Teller theory (BET theory). The mercury 
intrusion measurements were carried out on a Pascal 440 appa-
ratus by ThermoFinnigan (Thermo Fisher Scientific, Rochester, 
NY). A contact angle of 141.3° for Hg was used. The cumula-
tive pore volume at a given pressure represents the total volume 
of mercury taken up by the sample at that pressure. The mean 
pore diameter was calculated by applying the Washburn equa-
tion and a cylindrical pore model. Nitrogen sorption measure-
ments were performed by using a Sorptomatic 1990 apparatus 
by ThermoFinnigan (Thermo Fisher Scientific). All samples 
were degassed at 120°C before measurement for at least 
24 hours at 10−5 mbar. Adsorption and desorption isotherms 
were measured over a range of relative pressures (p/p0) from 
0 to 1.0. Surface areas were determined from the linear part 
of the Brunauer–Emmett–Teller equation in a relative pressure 
range (p/p0) of the adsorption isotherms between 0.05 and 0.25. 
A value of 0.162 nm2 was used for the cross-sectional area per 
nitrogen molecule. The total pore volume was estimated from 
the amount of gas adsorbed at the relative pressure p/p0 = 0.99 
assuming that pores were filled subsequently with condensed 
adsorptive in the normal liquid state.
By means of scanning electron microscopy (SEM) 
images, the morphology of the microparticles was exam-
ined and the particle size distribution was determined by 
application of 2D image analysis software MeX® (Alicona 
Imaging GmbH, Graz, Austria). An SEM image with a size 
of 175 × 175 microns was used for diameter analysis. All 
particles on the SEM image were labelled manually. This 
was done by marking the centre and edge of each particle. 
Particle number and radius were collected automatically by 
MeX. The particle size distribution was obtained by plotting 
the percentage of total particles against the particle diameter. 
SEM images were taken with a DSM960 scanning electron 
microscope (Carl Zeiss, Oberkochen, Germany).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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For transmission electron microscopical (TEM) imaging 
of the inner structure of the microparticles, the biomaterial 
was embedded in epoxy resin. A Leica EM UC6 microtome 
(Leica Gmbh, Wetzlar, Germany) equipped with a gem-grade 
diamond knife was used to cut ultrathin sections (typically 
40–50 nm). Thin slices were prepared onto carbon coated 
copper grids and examined with an EM912 transmission 
electron microscope (Carl Zeiss). For analyzing the shape of 
the synthetic HA crystals by means of TEM, a droplet of an 
HA/ethanol suspension was placed on a perforated carbon 
film. In traditional bright-field imaging mode, the contrast 
formation, when considered classically, is formed directly 
by occlusion and absorption of electrons in the sample. 
Thicker regions of the sample or regions with a higher atomic 
number will appear dark, while regions with no sample in 
the beam path will appear bright. Scanning transmission 
electron microscopy (STEM) images were taken by focus-
ing the electron beam into a narrow spot that is scanned over 
the sample in a raster using the same transmission electron 
microscope. Annular dark-field imaging is a method of map-
ping samples in a scanning transmission electron microscope. 
These images are formed by collecting scattered electrons 
with an annular dark-field detector.
Secondary electron STEM (STEM SE) imaging is a 
method of determining the topography of samples in a 
scanning transmission electron microscope. These images 
are formed by collecting secondary electrons with an SE 
detector.
The crystal phase of SIBS and human bone was analyzed 
by powder X-ray diffraction (PXRD). For X-ray diffrac-
tion measurements, the powdered samples were uniformly 
smeared onto a plastic sample holder using high-vacuum 
grease to assure a flat upper surface. X-ray diffraction pat-
terns of the samples were determined with monochromatic 
Cu Kα radiation, using an Inel position-sensitive detector 
(Inel Inc, Stratham, NH). X-ray diffraction measurements 
were calibrated with silicon powder.
Animal model
The experimental protocol was approved by local animal 
rights protection authorities and conducted according to 
EU guidelines for the care and use of laboratory animals. 
Male Wistar rats (body weight 350–450 g; Charles River 
Laboratories, Sulzfeld, Germany) were used for the experi-
ments and kept on water and standard laboratory chow, ad 
libitum. The rats were anesthetized with an intraperitoneal 
injection of 60 mg/kg of 6% sodium pentobarbital (Sigma, 
Deisenhofen, Germany). Anesthetized animals were placed 
in a supine position on a heating pad for maintenance of body 
temperature (36°C–37°C). After shaving an animal’s hind 
limb and disinfecting it, a 2 cm skin incision was made on 
the proximal area of the tibia to expose the tibia. A 3.5 mm 
diameter cortical defect was created using a dental drill (SU 
100, BEGO, Bremen, Germany) under constant irrigation 
with 0.9% saline. These defects were filled with SIBS. 
The wounds were closed with absorbable sutures (Marlin, 
Markneukirchen, Germany). A total of 52 rats were used; 
animals were sacrificed on days 3, 6, 9, 12, 21, 42, and 63 
after biomaterial implantation for routine histology (n = 7 
animals per time point). The remaining three rats were pre-
pared on day 9 for analysis by SEM.
histology of tissue implants
Tibia explants were fixed in 4% phosphate-buffered formalin 
for 2 days and then decalcified in 20% EDTA (pH 7.2–7.4) 
over 2 weeks. Decalcified tissue samples were embedded 
in paraffin. From the median parts of paraffin-embedded 
tissue blocks, 3 µm thick sections were cut and stained with 
hematoxylin-eosin (HE) for routine histological analysis.
histomorphometric analysis
Histomorphometry was performed on micrographs from the 
HE-stained sections using planimetric analysis (AxioVision, 
Zeiss, Jena, Germany). The images of the original defect 
regions were edited with Adobe Photoshop® (Adobe Systems, 
Mountain View, CA). The newly formed bone was marked 
at these images and analyzed (Analysis® software; Soft 
Imaging System GmbH, Muenster, Germany). The content 
of new bone formation was calculated as a percentage of 
the cortical wound and the medullary space. The number 
of remaining microparticles was counted as pieces per 
square millimeter.
ex vivo analysis of explants by seM and 
eDXs
Critical point drying (CPD) is a method of drying tissue 
without deforming the structure of wet, fragile specimens. 
Explants (n = 3) obtained after 9 days in rat tibia were 
prepared for SEM and EDXS analysis by critical-point 
drying in a CPD apparatus (K850 Critical Point Dryer, 
Quorum Technologies Ltd, East Grinstead, UK). For SEM 
analysis, the cross sections of the tibial defect area were 
sputter-coated with a 3 nm Au-Pd layer. Surface topogra-
phy of the biomaterial was examined using an accelerat-
ing voltage of 20 kV. The local chemical composition was 
analyzed by EDXS using a scanning electron microscope International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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DSM 960 (Carl Zeiss) equipped with an EDX system from 
SAMx (Saint Laurent Du Var, France). Cross sections of 
the tibial defect area were used without previous sputter-
coating. To compare change of the local chemical compo-
sition, microparticles before implantation were analyzed 
by EDXS.
statistical analysis
All data were uniformly distributed and therefore given as 
means ± standard error in the mean (sem). Analysis was 
performed using the software package Sigma-Stat (Jandel 
Corporation, San Rafael, CA).
Results
Material characterization
SEM images show that SIBS consists of microparticles 
with donut-like morphology (Figures 1A and 1B). The 
maximum particle size distribution ranges from 2–5 µm 
(Figure 2). This particle size was necessary to prevent the 
microparticles’ degradation by phagocytosis. A bulk density 
of 0.26 g/cm3 ± 0.05 g/cm3, a specific surface area of about 
168 m2/g, and a porosity of about 81% indicate SIBS as a 
highly porous bone graft substitute. The majority of the pores 
in the silica gel had sizes ranging from 10–50 nm in diameter 
and were interconnected (Figure 3). The inner structure and 
composition of the microparticles was investigated by means 
of TEM. Figure 4 shows a TEM image of a thin section 
(40 nm) of a resin-embedded microparticle. Significantly, a 
hollow space in the center of the donut-like microparticle is 
observable. Furthermore, it was found that the microparticles 
were surrounded by a darker, more compact zone. This was 
due to the spray-drying process, during which the solvent 
evaporated faster than the solid could diffuse. The material 
density at the particle surface should therefore be higher 
than in the interior. Figure 5A shows a TEM micrograph of 
a thin section (40 nm) near the surface of a resin-embedded 
microparticle. Thin platelets of HA are represented as dark 
platelet-shaped objects, perpendicular to the image plane, 
embedded in silica gel. In Figure 5B, a scanning dark-field 
(STEM DF) image of the same region is presented. It repre-
sents the complementary image of Figure 5A. The position of 
the HA crystals is more pronounced (white platelet-shaped 
objects) due to stronger scattering of HA compared with 
the silica gel. In Figure 5C a STEM-SE image of the same 
region is presented, showing the nanoporous structure of 
the silica gel matrix. Pores with pore sizes ranging from 
10–100 nm in diameter are observable and are intercon-
nected. In the upper left corner of Figures 5A–C, the outer 
edge of the microparticle is presented. As already mentioned, 
the material shows a denser structure in this area caused by 
the spray-drying   process. Figure 6 shows the X-ray diffrac-
tion pattern of the   biomaterial, the main diffraction peaks of 
stoichiometric HA, and, for comparison, the diffraction pat-
tern of human bone. The measurement proves that HA is the 
only crystal phase in our biomaterial. It is known that HA in 
human bone consists of nanocrystalline biological apatite.11 
Peak broadening of synthetic hydroxyapatite is similar to that 
of biological apatite in human bone, indicating a comparable 
A
B
Figure 1 representative electron microscopy images (A, B). seM images show that 
sIBs consists of microparticles with donut-like morphology.
Note: scale bars: A = 40 µm, B = 10 µm.
Abbreviations: seM, scanning electron microscopy; sIBs, synthetic injectable bone 
substitute.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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crystal size in both samples. The shape of the crystals was 
analysed by TEM. Figure 7 shows a TEM micrograph of the 
synthetic HA. Thin platelets 3–4 nm thick, 20–25 nm wide, 
and 50–70 nm long are observable.
histomorphometric analysis
Animals showed no abnormal behaviour after implanta-
tion of bone substitutes and revealed no postoperative 
complications.
SIBS and hematoma mixture in the centre of the wound 
could be observed on day 3. Small blood vessels and mesen-
chymal cells invaded the implanted biomaterial (  Figure 8A). 
New bone formation originated from endosteum on day 6. 
Loose connective tissue formed a scaffold with different 
cell types enclosing the microparticles. Some giant, multi-
nucleated osteoclast-like cells were observed around the 
biomaterial and newly formed bone on day 9 (Figure 8E). 
The hematoma disappeared on day 12 and the wound region 
was completely replaced by newly formed cancellous bone, 
fibrous tissue, and biomaterials. Osteoblast-like cells were 
clearly observed on the surface of newly formed bone. 
Some osteoblasts were trapped in lacunae, thus becoming 
osteocytes (Figure 8F). Due to the histological procedures, 
the hematomas within the biomaterials of the tissue samples 
were washed away on days 3, 6, and 9. Quantification 
analyses of newly formed bone and degradation of SIBS 
were performed at day 12. The extent of newly formed 
bone in the medullary space was 27.8% ± 1.3% on day 
12, which increased to 43.6% ± 2.4% on day 21 and step-
wise decreased to 5.7% ± 1.4% until day 63 (Figure 9A). 
  Conversely, new bone formation in cortical wounds increased 
from 32.0% ± 3.3% on day 12 to 67.8% ± 2.1% on day 63. 
The numbers of remaining microparticles in medullary 
space and cortical wound were ∼172/mm2 and ∼123/mm2 
on day 12 after implantation. Concomitantly, a reduction 
was observed in final numbers to ∼24/mm2 and ∼13/mm2 
on day 63 (  Figure 9B). The newly formed bone and bio-
materials in medullary space were almost resorbed on day 
63.   Repopulation with bone marrow in medullary space 
and lamellar bone regeneration in cortical wound indicates 
sufficient and almost complete bone remodelling.
ex vivo analysis
It is speculated that silica in the microparticles accelerates 
osteoinduction in bone defect. In support of this, quantitative 
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Figure 2 Quantitative analysis of particle size of the microparticles. The maximum 
of the particle diameter distribution from 2–5 µm is represented.
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Figure 3 Distribution of pore sizes within sIBs, as measured by mercury porosimetry. 
The majority of the pores in the silica gel have diameters ranging from 10–50 nm.
Abbreviation: sIBs, synthetic injectable bone substitute.
Figure 4 TeM image of a thin section (40 nm) of a resin-embedded microparticle. 
Significantly,  a  hollow  space  in  the  center  of  the  donut-like  microparticle  is 
observable. The microparticles are surrounded by a darker more compact edge.
Note: scale bar = 1 µm.
Abbreviation: TeM, transmission electron microscopy.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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analysis by means of EDXS showed that silicon disappeared 
and carbon increased, which further demonstrated the matrix 
change in SIBS over time.
In Figures 10A and 10B, SEM images of implanted 
microparticles are presented. An organic matrix formed on 
the surface by day 9 after implantation. The typical morphol-
ogy of implanted microparticles remained unchanged at day 
9 after implantation. EDXS was used to detect the in vivo 
change of the composition of the biomaterial (Figure 11). The 
red curve gives the composition of SIBS after production. 
Therefore, the composition of silica and HA is represented. 
At day 9 after implantation (blue curve represents SIBS at 
day 9 after implantation) HA was still visible, but the silicon 
peak dropped substantially. These results are representative 
for all samples. After 9 days in vivo, nearly all silica was 
replaced by organic autologous material. The shape of the 
microparticles did not change. Therefore, this matrix change 
cannot be considered as resorption of the biomaterial. The 
resorption was carried out by osteoclasts. Silica and HA 
are nearly insoluble at pH 7. In water, or in simulated body 
fluid, a change of the composition of the biomaterial was not 
observed (data not shown).
ABC
Figure 5 representative electron microscopy images of a thin section (40 nm) near the surface of a microparticle by means of TeM (A), scanning dark-field (STEM DF, B) and 
scanning secondary electron (sTeM se, C) providing nanostructural aspects of sIBs. Thin platelets of hA are represented as dark platelet-shaped objects, perpendicular to the 
image plane, embedded in silica gel (A). A sTeM DF image of the same region is presented (B). It represents the complementary image of (A). The position of the hA particles 
is more pronounced (white platelet-shaped objects) due to stronger scattering of hA compared with the silica gel. A sTeM se image of the same region is presented, showing 
the nanoporous structure of the silica gel matrix. Pores with pore sizes ranging from 10 nm to 100 nm in diameter are observable and are interconnected (C).
Note: scale bars: A, B, and C = 100 nm.
Abbreviations: TeM, transmission electron microscopy; hA, hydroxyapatite.
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Figure 6 representative XrD pattern of the biomaterial, the main diffraction peaks 
of stoichiometric hA and for comparison a diffraction pattern human bone. The 
measurements prove that hA is the only crystal phase in our biomaterial. The peak 
broadening of synthetic hydroxyapatite is similar to that of biological hydroxyapatite 
in human bone, indicating a comparable crystal size in both samples.
Abbreviations: XrD, X-ray diffraction; hA, hydroxyapatite.
Figure 7 The shape of the crystals was analyzed by TeM. A TeM micrograph of the 
synthetic hA shows thin platelets of 3–4 nm thick, 20–25 nm wide, and 50–70 nm long.
Note: scale bar = 50 nm.
Abbreviations: TeM, transmission electron microscopy; hA, hydroxyapatite.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Discussion
The present results demonstrate that a full synthetic 
injectable bone substitute significantly induced new bone 
  formation after implantation in tibial defects. Furthermore, 
it was almost absorbed after 63 days following replacement 
of the medullar cavity with marrow. We have already 
described the early matrix change of implanted NanoBone 
granules into adipose neck tissue in rats.10 The silica in these 
granules disappeared 12 days after implantation. In this 
study, the silica matrix of SIBS disappeared 9 days after 
AB
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9 d
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42 d
Figure 8 representative images of he-stained specimen of the rat tibial defect. Arrows in E and F point to the implanted microparticles. A–D show histological changes 
over time. Asterisks indicate the newly formed cancellous (E) and lamellar (F) bone. some giant, multinucleated osteoclast-like cells (arrowhead, E) and osteoblast layer in 
medullary space (arrowhead, F) are observed around the biomaterial and the new bone on day 9.
Note: scale bars: A, B, C, and D = 500 µm, E and F = 50 µm.
Abbreviation: he, hematoxylin-eosin.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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implantation, indicating a fast matrix change. In another 
study, the analysis after implantation of NanoBone block 
materials in minipigs have also shown a replacement of 
the silica gel matrix by a matrix of autologous organic 
molecules.12
Due to good clinical results, biomaterials were widely 
used for augmentation of osteoporotic vertebral compres-
sion fractures.13 On one hand, all kinds of natural and 
synthetic biomaterials can be modified as bone substi-
tutes, including gelatine, collagen, bioglass, and calcium 
phosphate. The choice of biomaterials as bone substitutes 
depends greatly on the application site, mechanical prop-
erties, osteoconduction, degradation behavior, and other 
factors. On the other hand, different architectural parameters 
of biomaterials, for example, structure, particle size, pore 
size, and interconnectivity, are very important for bone 
tissue engineering.14
The synthetic nanocrystalline HA is morphologically 
very similar to biological apatite in bone mineral, which 
has been widely used in clinical practice as a bone graft 
substitute. A variety of in vitro and in vivo experiments 
showed silicon rich biomaterials were biocompatible and 
bioactive with osteoconductive characters.15,16 Previous 
work suggested that HA with incorporation of silicate ions 
significantly improved in vivo bioactivity compared with 
conventional HA materials.17 Another study in patients 
demonstrated that a bone substitute comprised of nano-
crystalline hydroxyapatite embedded in a silica matrix was 
successful in oral and maxillofacial surgery.18 Based on 
a silica-embedded nanohydroxyapatite bone substitute, 
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Figure 9 Quantitative analysis of new bone formation (A, bone area as percent) and degradation (B, given as piece of square millimeter) in the cortical wound and the 
medullary space of he-stained specimen at day 12, 21, 42 and 63 after microparticle implantation.
Notes: Values are means ± sem; 7 animals per group.
Abbreviations: he, hematoxylin-eosin; sem, standard error in the mean.
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Figure 10 representative seM images (A, B) of sIBs 9 days after implantation. 
Arrows point to the implanted microparticles (A).
Note: scale bars: A = 20 µm, B = 9 µm.
Abbreviations: seM, scanning electron microscopy; sIBs, synthetic injectable bone 
substitute.
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Figure  11  eDXs  spectrum  analysis  of  sIBs  after  production  and  9  days  after 
implantation. silicon disappears 9 days after implantation and calcium increases, 
indicating a rapid matrix change with bone formation.
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we created a novel injectable biomaterial. It can be easy 
implanted in irregular bone defects through minimally inva-
sive surgical approaches. Any newly developed biomaterial 
should be tested for biocompatibility, potential inflamma-
tory reaction, and safety before clinical application. The rat 
tibial defect model is one of the methods commonly used 
for the evaluation of bone substitutes. Biomaterials have the 
potential to induce inflammatory reactions through direct 
contact with bone marrow cells.19 The high biocompatibility 
of SIBS is supported by the fact that neither leukocytes nor 
new formation of blood vessels surrounding the implants 
could be observed.
Following vascular invasion, mesenchymal stem cells of 
the bone marrow differentiate into osteogenic cells, includ-
ing osteoblasts, which are responsible for bone formation.3 
It seems that SIBS activates osteoprogenitor cells very 
quickly, with new bone formation at day 6. Inflammatory 
cells, including macrophages, produce cytokines and pro-
mote the differentiation of osteoclast precursors into mature 
osteoclasts, which play a prominent role in bone metabo-
lism.20 Since almost all microparticles were gone 63 days 
after implantation, it is hypothesized that the microparticles 
were degraded by osteoclasts.
A previous study by our group showed that the silica 
gel in the bone substitute NanoBone is replaced by bone 
matrix glycoproteins with known functions in attraction, 
adhesion, and differentiation of bone cells as osteoblasts 
and osteoclasts by 12 days after implantation in subcutane-
ous tissue.10 After implantation of SIBS into tibia defects, 
silica completely disappeared at day 9, indicating a rapid 
matrix change in bone regeneration. Silica has an important 
impact on regulation of generation, mobilization, differen-
tiation, and activation of osteoclast precursors.5 It has been 
established that a high silica content promotes rapid bone 
mineralization.21 To better understand SIBS bioactivity, 
further studies are required to determine silica metabolic 
pathways. Meanwhile, practical handling characteristics 
should be improved to facilitate application of the materials 
by clinicians.
Conclusion
With its unique nanostructure and composition, SIBS 
exhibits some biological characters of biocompatibil-
ity, osteoconduction, osteoproduction, and degradation. 
This novel injectable bone substitute can be used for 
treatment of irregular bone fractures and difficult surgical 
approaches.
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